Propofol Infusion Syndrome in a Patient with Epilepsia Partialis Continua
Journal of Korean Epilepsy Society
;
: 31-33, 2011.
Article
in Korean
| WPRIM
| ID: wpr-788620
ABSTRACT
Propofol has been used for the treatment of refractory status epilepticus, but propofol can cause propofol infusion syndrome (PRIS). PRIS is rarely developed and often fatal. The syndrome is characterized by metabolic acidosis, rhadomyolysis, and cardiac failure. Most reports were described in critically ill patients undergoing long-term propofol infusion at high doses. But many systemic confounding factors are mixed with the fatality of PRIS and there are no report on epilepsia partialis continua which has stable systemic conditions. We report PRIS in a patient with epilepsia partialis continua.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Status Epilepticus
/
Acidosis
/
Propofol
/
Epilepsia Partialis Continua
/
Critical Illness
/
Heart Failure
Limits:
Humans
Language:
Korean
Journal:
Journal of Korean Epilepsy Society
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS